The present invention relates to (1) an agent for preventing or treating estrogen receptor-negative and HER2-negative breast cancer comprising an Akt inhibitor, and (2) an estrogen receptor-negative, progesterone comprising an Akt inhibitor. Receptor-negative and HER2-negative breast cancer preventive or therapeutic agent, (3) Hormone receptor-negative and HER2-negative breast cancer preventive or therapeutic agent such as estrogen receptor and progesterone receptor using Akt inhibitory activity as an index Provide screening methods.
展开▼